نتائج البحث - "sodium-glucose cotransporter 2 inhibitors"

1

دورية أكاديمية

Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study.

المؤلفون: Su, Yu-Chi, Hsieh, Pei-Chun, Lai, Edward Chia-Cheng, Lin, Yun-Cian, Lin, Yu-Ching

المصدر: Diabetes & Metabolism; Jul2024, Vol. 50 Issue 4, pN.PAG-N.PAG, 1p

مصطلحات موضوعية: CARPAL tunnel syndrome, GLUCAGON-like peptide-1 receptor, SODIUM-glucose cotransporter 2 inhibitors, GLUCAGON-like peptide-1 agonists, TYPE 2 diabetes, SALT-free diet

2

دورية أكاديمية

Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study.

المؤلفون: Su, Yu-Chi, Hsieh, Pei-Chun, Lai, Edward Chia-Cheng, Lin, Yu-Ching

المصدر: Diabetes & Metabolism; Mar2024, Vol. 50 Issue 2, pN.PAG-N.PAG, 1p

مصطلحات موضوعية: SODIUM-glucose cotransporter 2 inhibitors, ROTATOR cuff, GLUCAGON-like peptide-1 receptor, SALT-free diet, TYPE 2 diabetes, PROPENSITY score matching, TOTAL shoulder replacement

3

دورية أكاديمية

Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review.

المؤلفون: Scheen, André J.

المصدر: Diabetes & Metabolism; Mar2024, Vol. 50 Issue 2, pN.PAG-N.PAG, 1p

مصطلحات موضوعية: TYPE 2 diabetes, GLUCAGON-like peptide-1 receptor, GLYCOSYLATED hemoglobin, SODIUM-glucose cotransporter 2 inhibitors, CORONARY artery disease

4

دورية أكاديمية

Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes.

المؤلفون: Huang, Yen-Min, Chen, Wan-Ming, Jao, An-Tzu, Chen, Mingchih, Shia, Ben-Chang, Wu, Szu-Yuan

المصدر: Diabetes & Metabolism; Jan2024, Vol. 50 Issue 1, pN.PAG-N.PAG, 1p

مصطلحات موضوعية: TYPE 2 diabetes, SODIUM-glucose cotransporter 2 inhibitors, OVERALL survival, SODIUM-glucose cotransporters, PROPENSITY score matching, CANCER patients

5

دورية أكاديمية

Sodium–glucose cotransporter-2 inhibitors for diabetic kidney disease: Targeting Warburg effects in proximal tubular cells.

المؤلفون: Morita, Miwa, Kanasaki, Keizo

المصدر: Diabetes & Metabolism; Oct2020, Vol. 46 Issue 5, p353-361, 9p

مصطلحات موضوعية: DIABETIC nephropathies, SODIUM-glucose cotransporter 2 inhibitors, MEDICAL research

6

دورية أكاديمية

Challenging 2019 ESC guidelines for the management of type 2 diabetes.

المؤلفون: Scheen, A.J.

المصدر: Diabetes & Metabolism; Jun2020, Vol. 46 Issue 3, p181-185, 5p

مصطلحات موضوعية: TYPE 2 diabetes, HEART failure, SODIUM-glucose cotransporter 2 inhibitors

7

دورية أكاديمية

Risk of bone fracture associated with sodium–glucose cotransporter-2 inhibitor treatment: A meta-analysis of randomized controlled trials.

المؤلفون: Cheng, L., Li, Y.-Y., Hu, W., Bai, F., Hao, H.-R., Yu, W.-N., Mao, X.-M.

المصدر: Diabetes & Metabolism; Oct2019, Vol. 45 Issue 5, p436-445, 10p

مصطلحات موضوعية: BONE fractures, RANDOMIZED controlled trials, SODIUM-glucose cotransporter 2 inhibitors, TYPE 2 diabetes, CANAGLIFLOZIN, META-analysis

8

دورية أكاديمية

Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies.

المؤلفون: Scheen, André J.

المصدر: Diabetes & Metabolism; Sep2023, Vol. 49 Issue 5, pN.PAG-N.PAG, 1p

مصطلحات موضوعية: STROKE, RANDOMIZED controlled trials, GLUCAGON-like peptide-1 agonists, GLUCAGON-like peptide-1 receptor, SODIUM-glucose cotransporter 2 inhibitors

9

دورية أكاديمية

Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study.

المؤلفون: Peng, Zi-Yang, Wang, Yao-Tseng, Chang, Chin-Sung, Wu, Chih-Hsing, Ou, Huang-Tz

المصدر: Diabetes & Metabolism; Sep2023, Vol. 49 Issue 5, pN.PAG-N.PAG, 1p

مصطلحات موضوعية: BONE fractures, TYPE 2 diabetes, TERIPARATIDE, SODIUM-glucose cotransporter 2 inhibitors, SURVIVAL rate, PEOPLE with diabetes

مصطلحات جغرافية: TAIWAN

10

Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors

المؤلفون: Mei-Zhen, Wu, Chanchal, Chandramouli, Pui-Fai, Wong, Yap-Hang, Chan, Hang-Long, Li, Si-Yeung, Yu, Yi-Kei, Tse, Qing-Wen, Ren, Shuk-Yin, Yu, Hung-Fat, Tse, Carolyn S P, Lam, Kai-Hang, Yiu

المساهمون: Cardiovascular Centre (CVC)

المصدر: Diabetes and Metabolism, 48(6):101367. MASSON EDITEUR

مصطلحات موضوعية: Male, Dipeptidyl-Peptidase IV Inhibitors, Pneumonia-related death, Endocrinology, Diabetes and Metabolism, General Medicine, Pneumonia, Middle Aged, Sodium-glucose cotransporter 2 inhibitors, Endocrinology, Dipeptidyl peptidase 4 inhibitors, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Sepsis, Internal Medicine, Infection-related death, Humans, Sepsis-related death, Female, Sodium-Glucose Transporter 2 Inhibitors

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b2e8162ea54b9ea4a2a4c55d2901a7Test
https://doi.org/10.1016/j.diabet.2022.101367Test

تنقيح النتائج